Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia

Bone Marrow Transplantation

Volumn 45, Issue 10, 2010, Pages 1508-1513

  Yagasaki, H ^a   Takahashi, Y ^a   Hama, A ^a   Kudo, K ^a   Nishio, N ^a   Muramatsu, H ^a   Tanaka, M ^a   Yoshida, N ^a   Matsumoto, K ^b   Watanabe, N ^c   Kato, K ^b   Horibe, K ^c   Kojima, S ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

Author keywords

aplastic anemia; GVHD; matched sibling donor; unrelated donor; viral infection

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; METHOTREXATE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CHIMERA; CHRONIC GRAFT VERSUS HOST DISEASE; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DONOR SELECTION; ENGRAFTMENT; EPSTEIN BARR VIRUS INFECTION; FEMALE; GRAFT FAILURE; GRAFT REJECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIBLING; SURVIVAL TIME; TREATMENT OUTCOME; VIRUS REACTIVATION;

ADOLESCENT; ANEMIA, APLASTIC; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GRAFT REJECTION; GRAFT VS HOST DISEASE; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SIBLINGS; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VIRUS ACTIVATION;

EID: 77957968817     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.378     Document Type: Article

References (29)

1. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med 1991; 324: 1297-1304.
2. Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A et al. Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood 1995; 85: 1348-1353.
3. Margolis D, Camitta B, Pietryga D, Keever-Taylor C, Baxter-Lowe LA, Pierce K et al. Unrelated donor bone marrow transplantation to treat severe aplastic anaemia in children and young adults. Br J Haematol 1996; 94: 65-72.
4. Deeg HJ, Seidel K, Casper J, Anasetti C, Davies S, Gajeweski JL et al. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immuno-suppressive therapy. Biol Blood Marrow Transplant 1999; 5: 243-252.
5. Horowitz MM. Current status of allogeneic bone marrow transplantation in acquire aplastic anemia. Semin Hematol 2000; 37: 30-42.
6. Passweg JR, Perez WS, Eapen M, Camitta BM, Gluckman E, Hinterberger W et al. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. Bone Marrow Transplant 2006; 37: 641-649.
7. Maury S, Balere-Appert ML, Chir Z, Boiron JM, Galambrun C, Yakouben K et al. Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipient. Haematologica 2007; 92: 589-596.
8. Kennedy-Nasser AA, Leung KS, Mahajan A, Weiss HL, Arce JA, Gottschalk S et al. Comparable outcomes of matched-related and alternative donor stem cell transplanta-tion for pediatric severe aplastic anemia. Biol Blood Marrow Transplant 2006; 12: 1277-1284.
9. Camitta BM, Thomas ED, Nathan DG, Santos G, Gordon-Smith EC, Gale RP et al. Severe aplastic anemia: a prospective study of the effect of early marrowtransplantation on acute mortality. Blood 1976; 48: 63-70.
10. Miyamura K, Kojima S, Takeyama K, Matsushita T, Fukuda M, Horibe K et al. Use of cyclophosphamide and total lymphoid irradiation combined with cyclosporine in bone marrow transplantation for transfused severe aplastic anemia. Bone Marrow Transplant 1988; 3: 457-461.
11. Azuma E, Kojima S, Kato K, Matsuyama T, Yamada Y, Kondo N et al. Conditioning with cyclophosphamide/antithy-mocyte globulin for allogeneic bone marrow transplantation from HLA-matched siblings in children with severe aplastic anemia. Bone Marrow Transplant 1997; 19: 1085-1087.
12. Kojima S, Inaba J, Yoshimi A, Takahashi Y, Watanabe N, Kudo K et al. Unrelated donor marrow transplantation in children with severe aplastic anaemia using cyclophosphamide, anti-thymocyte globulin and total body irradiation. Br J Haematol 2001; 114: 706-711.
13. Storb R, Deeg HJ, Farewell V, Doney K, Appelbaum F, Beatty P et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 1986; 68: 119-125. (Pubitemid 16041720)
14. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplant 1974; 18: 295-304.
15. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
16. Hoshino Y, Kimua H, Tanaka N, Tsuge I, Kudo K, Horibe K et al. Prospective monitoring of the Epstein-Barr virus DNA by a real-time quantitative polymerase chain reaction after allogenic stem cell transplantation. Br J Haematol 2001; 115: 105-111.
17. Kojima S, Matsuyama T, Kato S, Kigasawa H, Kobayashi R, Kikuta A et al. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood 2002; 100: 799-805.
18. Viollier R, Socie G, Tichelli A, Bacigalupo A, Korthof ET, Marsh J et al. Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplant 2008; 41: 45-50.
19. Vassiliou GS, Webb DK, Pamphilon D, Knapper S, Veys PA. Improved outcome of alternative donor bone marrow trans-plantation in children with severe aplastic anaemia using a conditioning regimen containing low-dose total body irradia-tion, cyclophosphamide and Campath. Br J Haematol 2001; 114: 701-705.
20. Brunstein CG, Weisdorf DJ, DeFor T, Barker JN, Tolar J, van Burik JA et al. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006; 108: 2874-2880.
21. Buyck HC, Ball S, Junagade P, Marsh J, Chakrabarti S. Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia. Bone Marrow Transplant 2009; 43: 813-816.
22. Armand P, Antin JH. Allogeneic stem cell transplantation for aplastic anemia. Biol Blood Marrow Transplant 2007; 13: 505-516.
23. Socie G, Henry-Amar M, Cosset JM, Devergie A, Girinsky T, Gluckman E. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 1991; 78: 277-279.
24. Kobayashi R, Yabe H, Hara J, Morimoto A, Tsuchida M, Mugishima H et al. Preceding immunosuppressive therapy with antithymocyte globulin and cyclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplant-ation from HLA-identical siblings. Br J Haematol 2006; 135: 693-696.
25. Bacigalupo A, Locatelli F, Lanino E, Marsh J, Socie G, Maury S et al. Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant 2005; 36: 947-950.
26. Deeg HJ, O'Donnell M, Tolar J, Agarwal R, Harris RE, Feig SA et al. Optimization of conditioning for marrow transplan-tation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. Blood 2006; 108: 1485-1491.
27. Lee JH, Choi SJ, Lee JH, Lee YS, Seol M, Ryu SG et al. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia. Bone Marrow Transplant 2005; 35: 755-761.
28. Siegal D, Xu W, Sutherland R, Kamel-Reid S, Kuruvilla J, Lipton JH et al. Graft-versus-host disease following marrow transplantation for aplastic anemia: different impact of two GVHD prevention strategies. Bone Marrow Transplant 2008; 42: 51-56.
29. Gupta V, Ball SE, Sage D, Ortin M, Freires M, Gordon-Smith EC et al. Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. Bone Marrow Trans-plant 2005; 35: 467-471.